- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on CD22 Positive in United Kingdom
Total 2310 results
-
Statens Serum InstitutCompleted
-
University of BirminghamHeart of England NHS TrustCompleted
-
University of OxfordCompletedTuberculosisUnited Kingdom
-
Minervax ApSSimbec ResearchCompleted
-
Queen Mary University of LondonImperial College London; University College, London; City, University of LondonActive, not recruiting
-
Nottingham University Hospitals NHS TrustTerminated
-
Barts & The London NHS TrustUnknownClostridium Difficile InfectionUnited Kingdom
-
ImmunoBiology LimitedSimbec Research; ORION Clinical Services; Oxford Therapeutics Consulting LimitedCompletedPneumococcal InfectionUnited Kingdom
-
NeuTec PharmaCompleted
-
University of OxfordImaxioCompletedTuberculosis (TB)United Kingdom
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
South Tyneside and Sunderland NHS Foundation TrustUnknownCentral Venous Cather PositionUnited Kingdom
-
University of NottinghamNational Institute for Health Research, United KingdomCompletedClostridium Difficile InfectionUnited Kingdom
-
University of OxfordCompletedHIV Infections | TuberculosisUnited Kingdom
-
Statens Serum InstitutCompleted
-
Minervax ApSCompleted
-
Imperial College LondonBristol-Myers Squibb; Merck Sharp & Dohme LLC; Gilead Sciences; ViiV Healthcare; Janssen...Active, not recruitingAgeing | HIV PositiveUnited Kingdom, Ireland
-
University of OxfordWellcome Trust; National Institute for Health Research, United Kingdom; University...Active, not recruitingTuberculosisUnited Kingdom
-
University of OxfordActive, not recruiting
-
Sanofi Pasteur, a Sanofi CompanyCompletedMeningitis | MeningococcemiaUnited Kingdom
-
University of OxfordUniversity of Southampton; University of Bristol; University of LondonCompleted
-
Public Health EnglandImperial College London; University College, London; Queen Mary University of... and other collaboratorsCompletedLatent Tuberculosis | TuberculosisUnited Kingdom
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
London North West Healthcare NHS TrustActive, not recruitingDiabetes Mellitus | TuberculosisUnited Kingdom
-
Queen Mary University of LondonCompletedRecurrent TuberculosisUnited Kingdom
-
University of OxfordCompleted
-
University of OxfordCrucell Holland BV; University of Birmingham; Emergent BioSolutions; AerasCompleted
-
University of OxfordUniversity of BirminghamCompletedTuberculosisUnited Kingdom
-
University College, LondonActive, not recruitingHIV | Latent TuberculosisUnited Kingdom
-
Public Health EnglandUnknownLatent Tuberculosis | Active TuberculosisUnited Kingdom
-
University of OxfordUniversity of Birmingham; AerasCompleted
-
University of OxfordRecruiting
-
PharmAthene UK LimitedNational Institute of Allergy and Infectious Diseases (NIAID)CompletedPrevention of Bacillus Anthracis (Anthrax) InfectionUnited Kingdom
-
University College, LondonNational Institute for Health Research, United KingdomCompletedTuberculosisUnited Kingdom
-
Imperial College LondonNovartis PharmaceuticalsCompletedChronic Myeloid Leukemia | Newly DiagnosedUnited Kingdom
-
University of LeedsGlaxoSmithKline; AstraZeneca; Sanofi Pasteur, a Sanofi Company; BioMérieux; Da Volterra and other collaboratorsCompletedClostridium Difficile InfectionUnited Kingdom
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma | CD20 PositiveUnited States
-
Nitric BioTherapeutics, IncTerminatedSkin Ulcers | Methicillin-resistant Staphylococcus Aureus InfectionUnited Kingdom
-
University of LiverpoolImperial College London; Newcastle University; University of GlasgowUnknownChronic Myeloid LeukaemiaUnited Kingdom
-
Barts & The London NHS TrustBritish Lung FoundationCompleted
-
National Cancer Institute (NCI)CompletedRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | CD20 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
Professor Mark WilcoxThe Leeds Teaching Hospitals NHS Trust; Astellas Pharma Europe Ltd.; St George...CompletedClostridium Difficile InfectionUnited Kingdom
-
Harvard University Faculty of MedicineNational Institute of Allergy and Infectious Diseases (NIAID); Sanofi; University... and other collaboratorsCompletedTuberculosisUnited States, Peru, United Kingdom
-
Genocea Biosciences, Inc.CompletedPneumococcal Infections | Pneumonia, PneumococcalUnited Kingdom
-
Public Health EnglandCompletedPneumococcal DiseaseUnited Kingdom
-
Medical Research CouncilUnknownLeukemiaUnited Kingdom
-
University of OxfordUniversity of BirminghamCompleted
-
Liverpool School of Tropical MedicinePfizerRecruitingStreptococcus PneumoniaUnited Kingdom
-
Public Health EnglandInstitute of Child Health; National Institute of Biological Standards and ControlCompletedPneumococcal Infections | Meningococcal InfectionsUnited Kingdom